A "Three-in-One" Multifunctional Probe for Bcl-2/Mcl-1 Profiling and Visualizing in Situ

Xiaodong Zhang1, Ziqian Wang2, Zongwei Guo3

  • 1State Key Laboratory of Fine Chemicals, School of Chemistry, Dalian University of Technology, No. 2 LingGong Road, Dalian, 116023, P. R. China.

Insights

Researchers developed a novel molecular probe to simultaneously detect and visualize Bcl-2 and Mcl-1 proteins, crucial in cancer. This tool aids in early diagnosis and targeted therapy for related diseases.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Chemical Biology

Background:

  • Bcl-2 family proteins, including Bcl-2 and Mcl-1, are key regulators of apoptosis.
  • These proteins are significant therapeutic targets in cancer treatment.
  • Current methods lack probes for simultaneous in situ profiling of both Bcl-2 and Mcl-1.

Purpose of the Study:

  • To develop a multifunctional molecular probe for simultaneous detection and visualization of Bcl-2 and Mcl-1.
  • To create a tool for in situ profiling, capturing, enriching, and bioimaging of Bcl-2 and Mcl-1.

Main Methods:

  • A "three-in-one" molecular design strategy was employed.
  • The probe (BnN3-OPD-Alk) integrates a Bcl-2/Mcl-1 binding ligand, a fluorescent reporter, and a photoreactive azido group.
  • The probe's affinity and fluorescence properties were characterized.

Main Results:

  • BnN3-OPD-Alk demonstrated sub-micromolar affinities for Bcl-2 and Mcl-1.
  • The probe exhibits bright green self-fluorescence.
  • Successful application in vitro and in cells for labeling, capturing, enriching, and bioimaging of Bcl-2 and Mcl-1.

Conclusions:

  • A novel multifunctional probe enables simultaneous in situ profiling of Bcl-2 and Mcl-1.
  • This strategy facilitates precise early diagnosis of diseases involving both proteins.
  • The probe offers potential for effective targeted therapy in dual Bcl-2/Mcl-1-related cancers.

Related Concept Videos